TIMOTHY MORSE: Open Payments
NPI 1811130867 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 47 payments from 16 companies in 2025. Trend: 2023 $1,030 · 2024 $747 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $139 |
| Novo Nordisk Inc | 6 | $94 |
| ABBVIE INC. | 5 | $82 |
| Exact Sciences Corporation | 5 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Lundbeck LLC | 3 | $56 |
| Dexcom, Inc. | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Amgen Inc. | 2 | $28 |
Products named: REXULTI, NURTEC ODT, UBRELVY, JARDIANCE, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, Rybelsus, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
